RANEXA 1000 MG

Država: Izrael

Jezik: engleski

Izvor: Ministry of Health

Aktivni sastojci:

RANOLAZINE 1000 MG

Dostupno od:

NEOPHARM LTD

ATC koda:

C01EB18

Farmaceutski oblik:

TABLETS EXTENDED RELEASE

Administracija rute:

PER OS

Proizveden od:

CV THERAPEUTICS INC, USA

Terapijska grupa:

RANOLAZINE

Terapijske indikacije:

Ranexa is indicated for the treatment of chronic angina. Ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).Ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers.

Datum autorizacije:

2010-10-01